Drug Discovery & Development Insights by OmicsX
No Result
View All Result
  • Login
  • Register
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
PRICING
SUBSCRIBE
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
No Result
View All Result
Drug Discovery & Development Insights by OmicsX
No Result
View All Result
Home Big Pharma

Bristol-Myers Squibb – Oncology Deals and Alliances Insights

Oncology Acquisitions, Deals & Collaboration Strategies

Team OmicsX by Team OmicsX
May 30, 2022
in Big Pharma, Channels, Deals & Collaborations (BP), Oncology
495
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Bristol-Myers Squibb (BMS) is an  American multinational pharmaceutical company, headquartered in New York City, develops and market innovative medicines for various disorders. BMS in its present form was formed in 1989, following the merger of its predecessors Bristol-Myers and the Squibb Corporation.

Support authors and subscribe to content

This is premium stuff. Subscribe to read the entire article.

Login if you have purchased

Subscribe

Gain access to all our Premium contents.
More than 100+ articles.
Subscribe Now

Buy Single Article

Unlock this article and gain permanent access to read it.
Unlock Now
Previous Post

BeiGene (Beijing) Co., Ltd-
Oncology Deals and Alliances Insights

Next Post

Eli Lilly and Company –
Oncology Deals and Alliances Insights

Next Post
Eli Lilly and Company – Oncology Deals and Alliances Insights

Eli Lilly and Company -
Oncology Deals and Alliances Insights

Drug Discovery & Development Insights by OmicsX

Mapping Bio-Innovations

updated.. easy.. precise... complete...

Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.

LEARN MORE »

  • Trending
  • Comments
  • Latest
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

May 30, 2022
Approved Oncology Targeting Small Molecule Kinase Inhibitors

Approved Oncology Targeting Small Molecule Kinase Inhibitors

May 30, 2022

Kinase Inhibitors in Preclinical Development – 2021

May 30, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

June 1, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

0
Hoffmann-La Roche – Oncology Drug Pipeline Insights – June 2021

Hoffmann-La Roche –
Oncology Drug Pipeline Insights – June 2021

0
AbbVie, Inc. – Oncology Drug Pipeline Insights – June 2021

AbbVie, Inc. –
Oncology Drug Pipeline Insights – June 2021

0
Amgen, Inc.  Oncology Drug Pipeline Analysis – June 2021

Amgen, Inc.
Oncology Drug Pipeline Analysis – June 2021

0
Emerging Drug Developers Developing Cancer Targeting Exosomes

Emerging Drug Developers Developing Cancer Targeting Exosomes

July 10, 2022
Cancer Microbiome Targeting Emerging Drug Developers

Cancer Microbiome Targeting Emerging Drug Developers

July 9, 2022
Antibody Drug Conjugates

Antibody Drug Conjugates

June 18, 2022
Oncolytic Viruses

Oncolytic Viruses

June 29, 2022

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

No Result
View All Result
  • Home
  • Subscription
  • Category
    • Opinion
    • Tech
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?